These findings extend our knowledge about EBV such that although EBV is recognized as an oncogenic virus, some products of EBV, such as LMP2A, may down-regulate HER2 expression and possibly be helpful to improve outcomes in gastric carcinoma patients. This evidence concerns the gene ERBB2 and gastric carcinoma.